Wells Fargo raises Immunovant target price to $47 from $45
IMVT•Wells Fargo raised its target price for Immunovant to $47 from $45.
Related News
FuelCell Energy joins DOE lab-led AI data center power project
FCEL•
Israel's BrainsWay Q3 revenue rises on OCD coil sales
BWAY•
Euro zone 10-year yields ease, but rate hike concerns linger
TLT•
Founder Group swings to net profit of RM 791,785 for six months ended June 30, 2026
FGL•
BoE's Lombardelli sees conditions for persistent inflation crystallising
TLT•